Catheter with fluid medication injectors

Abstract: A device for injecting medication into a vessel wall includes an inflatable balloon mounted on a catheter. Additionally, a plurality of tubular fluid passageways are longitudinally mounted on the balloon, and a plurality of injectors are mounted on each tubular passageway and in fluid communication therewith. During use of the device, the balloon is first positioned in a vessel. The balloon is then inflated to embed the injectors into the vessel wall. Next, a fluid medicament is introduced through each of the fluid passageways for further infusion through the passageways and through the injectors into the vessel wall.

Description: The present invention pertains generally to invasive medical devices which are useful for the purpose of infusing fluid medicaments into a patient. More specifically, the present invention pertains to medical devices which can be inserted into a vessel of a patient's cardiovascular system. The present invention is particularly, but not exclusively, useful for infusing fluid medicaments directly into a vessel wall. BACKGROUND OF THE INVENTION Depending on the particular ailment it is known in the medical field that fluid medications can be infused directly into the wall of a vessel of a patient's cardiovascular system with beneficial results. For example, one such application involves the administration of medicaments into an arterial wall which will inhibit or prevent the restenosis of plaque in the artery. Any procedure involving the direct infusion of fluid medicaments into a vessel wall, however, requires the consideration of several factors. First, the procedure must be safe. For instance, due to the toxic nature of some medicaments, such a procedure must insure that only minimal amounts of medication are ever washed away into the blood stream and not actually infused into the vessel wall. Second, the device which infuses the medication into the vessel wall must be easy to use, accurate in its delivery capability and reliable in its operation. Several devices have been suggested for the purpose of infusing fluid medicaments directly into a vessel wall. One example of such a device is disclosed in U.S. Patent No. 5,354,279 which issued to Hofling for an invention entitled "Plural Needle Injection Catheter". The specific device disclosed in this patent employs prebent hollow needles which are extendable from a catheter to penetrate into a vessel wall. The extended needles are then used for infusion of the fluid medicament. Also, U.S. Patent No. 5,364,356, was issued to Hofling for another invention entitled "Sleeve Catheter". This second patent to Hofling discloses a device which employs a balloon expandable sleeve that delivers fluid medication to a vessel wall. More specifically, this device of Hofling's includes a reconfigurable sleeve which is expanded by an inflatable balloon. It is intended that, as the sleeve expands, openings which are formed into the sleeve spread to discharge fluid medications onto the surface of the vessel walls. Still another example of a device for medicating a vessel wall is disclosed in U.S. Patent No. 5,112,305 which issued to Barath et al. for an invention entitled "Catheter Device for Intramural Delivery of Therapeutic Agents". This same device is also disclosed in a related U.S. Patent No. 5,242,397 which issued to Barath et al. for an invention entitled "Catheter Device and Method of Use for Intramural Delivery of Protein Kinase C and Tyrosine Protein Kinase Inhibitors to Prevent Restenosis after Balloon Angioplasty". Specifically, the device disclosed by Barath et al. employs a balloon which requires an initial slow filling of the balloon with a medicament to expand the balloon and position the balloon's surface against the vessel wall. This initial slow filling is then followed by a rapid filling of the balloon which reconfigures tubular extensions on the surface of the balloon for the infusion of medicaments through the tubular extensions and into the vessel wall. US 5,336,178 (Kaplan et al ) relates to an intravascular catheter with means for infusing an agent into a treatment site in a body lumen and means for deploying the infusion means adjacent the treatment site which operate independently of one another. More specifically, the device comprises an inflatable balloon, an infusion array having delivery conduits and orifices, and means for ejecting the agent from the infusion array into the vessel wall. The infusion array with its delivery conduits and orifices is disposed about the exterior of the balloon, whereby the conduits and orifices are configured to infuse the agent at sufficient pressure to penetrate into the vessel wall. None of the above discussed devices, however, address the problem from the same perspective as the present invention. Specifically, the present invention recognizes that it is preferable to have a mechanism for infusing medication into a vessel wall which is independent and separately operable from the mechanisms which position the device in the artery and which cause at least one medication injector to penetrate into the vessel wall. Consequently, as recognized by the present invention, it is preferable to isolate the mechanism for actual infusion of medications into the vessel wall from other operable mechanisms of the device. Further, the present invention recognizes that, depending on the nature and condition of the vessel wall, it is preferable to have the capability of selectively applying a variable force to the injectors of the device as they penetrate into the vessel wall. In light of the above, it is an object of the present invention to provide a device for injecting medication into the wall of a vessel which includes a mechanism for penetrating a vessel wall with medication delivery injectors that is separate from the mechanism which infuses the medication into the vessel wall. It is another object of the present invention to provide a device for injecting medication into the wall of a vessel which can selectively vary the force that is used to penetrate the vessel wall with a fluid medication injector. Still another object of the present invention is to provide a device for injecting medication into the wall of a vessel which is easy to use, relatively simple to manufacture and comparatively cost effective. SUMMARY OF THE INVENTION In accordance with the present invention, a device for injecting medication into the wall of a vessel is provided comprising the features of claim 1. This device includes an inflatable PET balloon which is mounted on a multi-lumen catheter. A flexible tubular sleeve, preferably made of polyurethane, is provided. This sleeve effectively surrounds most of the inflatable balloon, and thereby creates an infusion chamber between the balloon and the sleeve. To create this chamber, the distal end of the tubular sleeve is attached directly onto the surface of the balloon, and the proximal end of the sleeve is extended proximally from the balloon. The open proximal end of the tubular sleeve thus establishes a port for fluid access into the infusion chamber. For the device of the present invention, a plurality of injectors are mounted directly onto the sleeve and are placed in fluid communication with the infusion chamber. More specifically, each injector includes a base plate and a hollow protrusion which projects from the base of the injector to create a fluid channel through the injector. To establish a fluid path from the infusion chamber through the channel of the injector, the base of the injector is mounted onto the tubular sleeve over holes that may either be preformed into the sleeve or formed into the sleeve after the injectors have been attached to the sleeve. The device of the present invention also includes a system for selectively inflating the balloon. As intended for the present invention, the balloon inflating system can be directly connected to a lumen of the catheter. The catheter lumen, in turn, is in fluid communication with the interior of the inflatable balloon. Additionally, the device includes a fluid pump which is engageable in fluid communication with the infusion chamber between the balloon and the sleeve for injecting fluid medicaments from a fluid source into the infusion chamber. Further, in an alternate embodiment of the present invention, instead of having single port injectors, a plurality of hollow protrusions can be formed onto the same base plate to create an injector having a plurality of outlet ports. In the operation of the device of the present invention, a guidewire is first positioned into an artery of the patient. This is done to establish a mechanical pathway through the artery to the site where the fluid medication is to be infused. The extracorporeal end of the guidewire is then inserted into a lumen of the catheter and the balloon on the catheter is advanced over the guidewire and to the site where the medication is to be infused. Once the balloon has been properly positioned for the infusion of fluid medicaments into the arterial wall, the balloon is inflated. This inflation of the balloon, in turn, urges the tubular sleeve to move outwardly with the expansion of the balloon. This action also causes the injectors to penetrate into the arterial wall. After the balloon has been inflated, and while the injectors remain penetrated into the arterial wall, the fluid pump is activated to inject fluid from the fluid source into the infusion chamber. Importantly, this pumping action also forces fluid from the infusion chamber through the injectors and into the arterial wall. In yet another alternative embodiment of the present invention, the tubular sleeve which surrounds the inflatable balloon is replaced with a plurality of tubular fluid passageways. These passageways, unlike the tubular sleeve of the previous embodiment, are smaller in diameter than the inflatable balloon and are mounted directly onto its exterior surface. Each passageway is oriented in a substantially longitudinal direction and thus establishes a distal end and a proximal end for the passageway. The distal end of each passageway is sealed to create an infusion duct, and the proximal end of each passageway extends proximally from the balloon to establish a port for fluid access into the fluid duct. Similar to the previous embodiment having a tubular sleeve, each tubular fluid passageway has at least one injector mounted directly onto its external surface and in fluid communication with the infusion duct. The injectors are located on the surface of the passageway such that upon inflation of the balloon, the injectors travel outwardly in a radial direction. As the balloon continues to expand, each passageway is urged against the arterial wall such that the injectors penetrate into the arterial wall. The process of injecting a medicament using the embodiment having a tubular fluid passageway is similar to the process using the embodiment with a tubular sleeve. More specifically, the inflatable balloon is positioned along a guide wire in an artery and inflated such that the injectors penetrate the walls of the artery. However, instead of injecting fluid into the infusion chamber created by the tubular sleeve, fluid is injected into the infusion duct created by the tubular fluid passageway. As fluid is pumped into the infusion duct, it is likewise pumped out through the injectors and infused into the arterial wall. Unlike the embodiment with the tubular sleeve, however, each tubular fluid passageway has its own port. Thus, it is possible to administer a variety of medicaments simultaneously, or to administer a particular medicament through one or more selected passageways. BRIEF DESCRIPTION OF THE DRAWINGS The novel features of this invention, as well as the invention itself, both as to its structure and its operation will be best understood from the accompanying drawings, taken in conjunction with the accompanying description, in which similar reference characters refer to similar parts, and in which: Figure 1 is a perspective view of a patient with the catheter of the present invention positioned in an artery of the patient for operation of the device; Figure 2 is a perspective view of the device of the present invention; Figure 3 is a cross-sectional view of the device of the present invention as seen along the line 3-3 in Figure 2 and positioned in an artery of a patient for infusion of fluid medications into the arterial wall; Figure 4A is a perspective view of an embodiment for a single port injector of the present invention; Figure 4B is a perspective view of another embodiment for a single port injector of the present invention; Figure 5A is a perspective view of an embodiment of a multi-port injector of the present invention; Figure 5B is a perspective view of another embodiment of a multi-port injector of the present invention; Figure 6 is a perspective view of another embodiment of the present invention; and Figure 7 is a cross-sectional view of the device of the present invention as seen along line 7-7 in Figure 6. DESCRIPTION OF THE PREFERRED EMBODIMENTS Referring initially to Figure 1, a device for injecting fluid medication into the wall of a vessel in accordance with the present invention is shown and generally designated 10. More specifically, the device 10 is shown positioned in the artery of a patient 12. As will be appreciated by the skilled artisan, the device 10 is shown schematically positioned in the patient 12, and it is to be understood that use of the device 10 is not confined to only upper body arteries and vessels but, instead, can be used in arteries and vessels throughout the patient 12. Figure 2 clearly shows that the components of device 10 include a multi-lumen catheter 14 which has an inflatable balloon 16 mounted thereon. Further, Figure 2 indicates that a tubular sleeve 18 surrounds a substantial portion of the inflatable balloon 16, and that a plurality of injectors 20 are mounted onto the sleeve 18. Of these, the injectors 20a-20b are only exemplary. For purposes of the present invention, balloon 16 is preferably made of polyethylene terephthalate (PET). Additionally, the sleeve 18 can also be made of polyethylene terephthalate (PET). A more complete appreciation of the structural cooperation between balloon 16, sleeve 18 and the injectors 20 is provided by Figure 3 wherein it will be seen that the distal end 22 of sleeve 18 is attached directly to the surface of balloon 16. Figure 3 also shows that the tubular sleeve 18 substantially surrounds the balloon 16 and that the proximal end 24 of sleeve 18 extends proximally from and beyond the balloon 16 over catheter 14. With this structural relationship, an infusion chamber 26 is formed between the balloon 16 and the sleeve 18. Additionally, as best seen in Figure 3, a fluid port 27 is formed between the sleeve 18 and catheter 14 through which fluid medication can be injected into the infusion chamber 26. Figure 3 further shows that the distal end 28 of balloon 16 is affixed to the catheter 14, and that the proximal end of the balloon 16 closes onto the catheter 14 to create an inflation chamber 32 in the interior of the balloon 16. A port 34 is shown which provides fluid access into the inflation chamber 32. For purposes of the present invention, the port 34 can be connected in fluid communication with a lumen (not shown) of the catheter 14. Figure 3 also shows that catheter 14 is formed with a lumen 36 which is dimensioned to receive a guidewire 38 therethrough. Turning now to Figure 4A, an injector 20 is shown to include a base plate 40 and a hollow protrusion 42 which projects therefrom. Further, it is seen that the end 44 of body 42 is affixed to or integral with the base plate 40. Preferably, the injector 20 is made of nickel and the protrusion 42 is formed by punching out the base plate 40. In any event, a cutting edge 46 is formed around the end of body 42 that is opposite from the end 44 on plate 40 and the resultant structure establishes a fluid channel 48 which extends through the injector 20. As shown, the injector 20 has a substantially cylindrical shaped protrusion 42. In Figure 4B, another embodiment for an injector of the present invention is shown and designated 70. Rather than having a cylindrical shaped protrusion 42 like the injector 20, however, the injector 70 has a substantially conical shaped protrusion 72. Like injector 20, the injector 70 is preferably made of nickel and is formed to have a fluid channel 48 which extends through the injector 70. For a multi-port injector version of the present invention, a plurality of protrusions 42 can be formed from the same base plate. Figure 5A shows such an embodiment. Specifically, Figure 5A shows an elongated base plate 50 from which the protrusions 42a', 42b' and 42c' have been formed. In all important respects, the protrusions 42' shown in Figure 5A are structurally the same as the protrusion 42 discussed above with reference to Figure 4A. The only difference being that they are collectively mounted on the same base plate 50. Similarly, Figure 5B shows a multi-port injector wherein the protrusion 72a', 72b' and 72c' have been formed from a base 50. In all important respects, the protrusions 72' shown in Figure 5B are structurally the same as the protrusion 72 discussed above with reference to Figure 4B. Again, the only difference being that they are collectively mounted on the same base plate 50. For purposes of the present invention, the injectors 20 are mounted onto the sleeve 18 so that the channel 48 of each respective injector 20 is aligned with a hole 52 in the sleeve 18. This is done to establish fluid communication between the particular injector 20 and the infusion chamber 26. As a practical matter, it may be preferable in the construction of the device 10 to first mount the injector 20, 70 onto sleeve 18, which can be done in any manner well known in the pertinent art, such as by bonding, and then pierce the sleeve 18 through the channel 48. In the operation of the present invention the guidewire 38 is first positioned in the vessel to establish a mechanical path for the device 10 to the site, as shown in Figure 3, where fluid medications are to be infused into a vessel wall 54. Once the balloon 16 of device 10 is properly positioned, an inflator 56 is activated to inflate the balloon 16. As shown in Figure 2, inflator 56 is connected to the proximal (extracorporeal) end of the device 10. Referring back to Figure 3, it will be appreciated that, as balloon 16 is inflated, the expanding balloon 16 urges against the tubular sleeve 18 and causes the sleeve 18 to likewise expand. Consequently, the injectors 20,70 which are mounted on the surface of sleeve 18 move radially from the catheter 14 and are embedded into the vessel wall 54. With the injectors 20,70 embedded into the vessel wall 54, the fluid pump 58 shown in Figure 2 is activated to pump fluid from the fluid source 60 into the infusion chamber 26 through the port 34. Importantly, this pumping action also causes any fluid medication which has already been pumped into the infusion chamber 26 to be expelled through the channels 48 of injectors 20,70 and into the tissue of vessel wall 54. After the fluid medication from fluid source 60 has been infused into the vessel wall 54, the balloon 16 can be deflated by reversing the inflator 56. This action will cause the balloon 16 to collapse and to thereby withdraw the injectors 20,70 from the vessel wall 54. The entire device 10 can then be withdrawn from the patient 12 over the guidewire 38. In Figure 6, another preferred embodiment of the present invention is shown. The perspective view in Figure 6 shows the basic components of device 100, namely, a multi-lumen catheter 14, an inflatable balloon 16 formed to accommodate guide wire 38, and a plurality of tubular fluid passageways 102 mounted on the external surface of balloon 16. Each tubular fluid passageway 102 has a smaller diameter than balloon 16 and is positioned to be substantially parallel with the longitudinal axis of balloon 16. Figure 6 further shows that mounted on the surface of each tubular fluid passageway 102 is a plurality of injectors 70. Those injectors 70 are positioned on the outside surface of tubular fluid passageway 102 such that when balloon 16 is inflated, injectors 70 move outwardly in a radial direction. Note, however, the showing of injector 70 is for illustration purposes only and it should be appreciated that any injector or combination of injectors 20/70 discussed in association with the previous embodiments may be used. Referring now to Figure 7, the cross-sectional view of device 100 shows the tubular fluid passageway 102 in more detail. More specifically, distal end 104 of tubular fluid passageway 102 is sealed to create an infusion duct 108. At proximal end 106 of the tubular fluid passageway 102, port 110 provides fluid access between infusion duct 108 and catheter 14 (not shown). Referring back to Figure 2, it is appreciated that the proximal (extracorporeal) end of device 100 establishes fluid communication between fluid pump 58 and infusion duct 108. Returning to Figure 7, injectors 70 are shown mounted on the external surface of tubular fluid passageway 102. As Figure 7 further shows in detail, base 40 of injector 70 is mounted on tubular fluid passageway 102 over a corresponding hole 112. From this view, it can be appreciated that any number of tubular fluid passageways 102 could be mounted on the external surface of balloon 16. It is further appreciated that any number of injectors 70 could be mounted on a single tubular fluid passageway 102. Despite the structural differences between the preferred embodiments as discussed above, all of the preferred embodiments operate in much the same manner. More specifically, referring back to Figure 3, following the positioning of balloon 16 in a vessel, balloon 16 is inflated. As the balloon 16 expands, injectors 70 on tubular fluid passageway 102 are embedded into the vessel wall 54, precisely as detailed above in connection with the previous embodiments. There is, however, a distinction between the embodiments with respect to the connection and activation of fluid pump 58. More precisely, because it is possible to have a plurality of tubular fluid passageways 102, it is likewise possible to either maintain fluid communication with, or fluid isolation between, each tubular fluid passageway 102. For example, fluid communication between tubular fluid passageways 102 can be established by fluidly connecting ports 110 together within catheter 14 such that port 110 of each tubular fluid passageway 102 is supplied fluid from the same fluid pump 58. Alternatively, fluid isolation may be maintained between each tubular fluid passageway 102 by providing each port 110 with a corresponding lumen in catheter 14 establishing its own fluid connection to a corresponding fluid pump 58. Consequently, it is possible to inject a variety of medicaments simultaneously by using a plurality of fluid pumps 58. While the particular device for injecting medication into the wall of a vessel as herein shown and disclosed in detail is fully capable of obtaining the objects and providing the advantages herein before stated, it is to be understood that it is merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended to the details of the construction or design herein shown other than as defined in the appended claims.

Claims: A device for injecting a fluid medicament into a wall of a vessel which comprises: an inflatable balloon (16); means (18,26) for carrying the fluid, the means for carrying being mounted to the balloon (16), means for injecting the fluid from the means for carrying the fluid into the vessel wall, characterised in that the device further comprises at least one injector (20,70) for penetrating the wall of the vessel, the injector being mounted to and projecting away from the means (18,26) for carrying the fluid, the injector (20,70) being in fluid communication with the means for carrying the fluid; and means for inflating the balloon (16) so that injector (20,70) penetrates into the vessel wall. A device as recited in Claim 1 wherein the means for carrying the fluid includes at least one tubular sleeve (18) which defines an infusion chamber (26). A device as recited in Claim 2 wherein the injector includes a base (40) secured to an external, outer surface of the tubular sleeve (18). A device as recited in Claim 2 wherein the tubular sleeve (18) substantially encircles at least a portion of the balloon (16). A device as recited in Claim 1 wherein the injector (20) includes a base (40) and a hollow protrusion (42,72) projecting away from the base, the protrusion (42,72) having a first end (44) and a second end, the first end (44) of the protrusion being affixed to the base (40) and the second end formed with a cutting edge (46). A device as recited in Claim 5 which comprises a plurality of injectors (20). A device as recited in Claim 5 further comprising a plurality of the protusions (42,72) projecting from the base (50). A device as recited in Claim 5 wherein the protusion (42) is substantially cylindical shaped. A device as recited in Claim 5 wherein the protusion (72) is substantially conical shaped. A device as recited in Claim 1 which further comprises a catheter (14) formed with a plurality of lumens, one of the lumens being dimensioned to receive a guidewire (38) therethrough for guiding and positioning the balloon in the vessel. A device as recited in Claim 10 wherein one of the lumens of the catheter (14) establishes fluid communication between the balloon (16) and the inflating means.

Inventors: BARATH PETER, VIGIL DENNIS M, BARATH, PETER, VIGIL, DENNIS M.
Applicants: INTERVENTIONAL TECHNOLOGIES, INTERVENTIONAL TECHNOLOGIES INC
Application year: 1996
Main classification: A61M25
IPC codes: A61M25, A61M29, A61M5